IGF-1 DES
A truncated IGF-1 analog that remains a familiar name in performance and tissue-growth peptide discussions.
Also referenced as: IGF-1 DES(1-3)
Also appears in: Growth Hormone
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary lane: Muscle Growth. Also surfaces under Growth Hormone for browsing and discovery.
IGF-1 DES(1-3)
No FDA label signal · 0 trials · 0 PubMed results
What IGF-1 DES is
IGF-1 DES is a truncated analog of insulin-like growth factor 1, typically discussed in performance and tissue-growth circles rather than mainstream medicine.
Why it matters
It is still one of the more recognizable growth-factor names missing from many peptide libraries, especially for users who know the difference between growth hormone secretagogues and direct growth-factor analogs.
Regulatory context
IGF-1 DES is not FDA approved as a mainstream therapeutic product. It fits best in the research-market category.
Practical reading note
Because IGF-1 language sounds medical and familiar, this is one of the easier compounds for people to overread. The research-market versions are not the same as a broadly established drug pathway.